NewsRx

Search our medical news database

Prostate Cancer

Not Enough Data To Recommend Brachytherapy Over Standard Therapy - Yet

Published in Cancer Weekly, April 17th, 2001

A new study says there is insufficient evidence to recommend unconditionally the use of brachytherapy over current standard therapy for localized prostate cancer.

Despite the absence of data from randomized clinical trials, brachytherapy - the implantation of radioactive seeds - has emerged as an alternative to current standard localized prostate cancer therapy. The paucity of evidence notwithstanding, both urologists and patients are attracted to brachytherapy because it is a minimally-invasive alternative to radical prostatectomy and external beam radiotherapy.

The Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook